Gilead Sciences (GILD) Intangibles (2009 - 2026)
Gilead Sciences (GILD) recorded Intangibles of $14.03 billion in Q2 2026, down 24.4% from $18.57 billion a year earlier and down 14.3% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Intangibles of $16.98 billion, down 14.9% from FY2024.
- Annual Intangibles has declined for four straight years, with a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $19.95 billion in FY2024 (-24.6%), $26.45 billion in FY2023 (-8.4%), $28.89 billion in FY2022 (-13.6%) and $33.46 billion in FY2021 (+1.0%).
- The Q2 2026 figure is the lowest quarterly Intangibles since Q3 2020.
- On a year-over-year basis, Intangibles has declined for 18 consecutive quarters, with an average decline of 19.0% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 162.0% in Q3 2021, against a decline of 24.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.38 billion (Q1 2026), $16.98 billion (Q4 2025) and $17.97 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.03 Bn |
| Mar 31, 2026 | 16.38 Bn |
| Dec 31, 2025 | 16.98 Bn |
| Sep 30, 2025 | 17.97 Bn |
| Jun 30, 2025 | 18.57 Bn |
| Mar 31, 2025 | 19.36 Bn |
| Dec 31, 2024 | 19.95 Bn |
| Sep 30, 2024 | 20.55 Bn |
| Jun 30, 2024 | 22.83 Bn |
| Mar 31, 2024 | 23.43 Bn |
| Dec 31, 2023 | 26.45 Bn |
| Sep 30, 2023 | 27.15 Bn |
| Jun 30, 2023 | 27.75 Bn |
| Mar 31, 2023 | 28.35 Bn |
| Dec 31, 2022 | 28.89 Bn |
| Sep 30, 2022 | 29.44 Bn |
| Jun 30, 2022 | 29.89 Bn |
| Mar 31, 2022 | 30.33 Bn |
| Dec 31, 2021 | 33.46 Bn |
| Sep 30, 2021 | 33.90 Bn |
API Access
Gilead Sciences Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();